Skip to content

Public FDA record

Z-0090-04: Device to determine quantitative total testosterone in human serum

Recall record Z-0090-04 for Qualigen Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0090-04
Company in FDA record
Qualigen Inc
FDA classification date
Nov 6, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Kits may produce results that are falsely elevated.

Source facts

Action
All customers who received any one of the three lots have been faxed a removal letter starting 09/24/03. Certified or Airborne letter sent on 09/29/03.
Initiated
2003-09-19
Root cause
Other
Terminated
2004-03-30
Distribution
Nationwide and Switzerland.
Recall number
Z-0090-04
Recall status
Terminated
CDRH record ID
30085
FDA classified
2003-11-06
Recall event number
27562

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗